Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.4B | 9.9B | 8.0B | 7.9B |
Cost of revenue | 7.0B | 7.9B | 5.5B | 5.4B |
Gross profit | 2.4B | 2.0B | 2.5B | 2.6B |
Operating expense | ||||
Research & development | 392.0M | 310.7M | 362.0M | 255.5M |
Selling general and admin | 1.2B | 1.1B | 1.5B | 1.5B |
Other operating expenses | 41.5M | 56.4M | 31.5M | 30.4M |
Operating income | 787.5M | 656.4M | 642.9M | 815.9M |
Non operating interest income | ||||
Income | 54.1M | 60.2M | 57.1M | 54.3M |
Expense | 86.1M | 106.0M | 72.6M | 74.5M |
Other income expense | — | — | — | — |
Pretax income | 814.2M | 512.7M | 676.9M | 831.7M |
Tax provision | 143.2M | 20.0M | 102.1M | 146.9M |
Net income | 671.0M | 492.7M | 574.8M | 684.8M |
Basic EPS | 0.6 | — | — | — |
Diluted EPS | 0.6 | — | — | — |
Basic average shares | 1.1B | — | — | — |
Diluted average shares | 1.1B | — | — | — |
EBITDA | 933.0M | 677.3M | 775.8M | 977.4M |
Net income from continuing op. | — | — | — | — |
Minority interests | -17.9M | -65.8M | -11.3M | -12.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |